CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guy, B.
Right arrow Articles by Trannoy, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guy, B.
Right arrow Articles by Trannoy, E.

Clinical and Diagnostic Laboratory Immunology, March 2000, p. 314-317, Vol. 7, No. 2
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Comparison of Polymorphonuclear Cells from Healthy Donors and Differentiated HL-60 Cells as Phagocytes in an Opsonophagocytic Assay Using Antigen-Coated Fluorescent Beads

Bruno Guy,* Catherine Testart, Sophie Gimenez, Violette Sanchez, Philippe Lheritier, Danielle Rossin, Michèle Mignon, Bernard Danve, and Emanuelle Trannoy

Research Department, Aventis Pasteur, Campus Merieux, 69280 Marcy L'Etoile, France

Received 3 September 1999/Returned for modification 9 November 1999/Accepted 8 December 1999

Polymorphonuclear cells (PMNs) from healthy donors and differentiated HL-60 cells were compared in an opsonophagocytic assay using fluorescent latex beads coated with Streptococcus pneumoniae polysaccharide conjugates. Serum-specific phagocytosis was efficiently mediated by both sources of cells, as measured by flow cytometry, but the mean number of beads ingested per cell was three- to fivefold higher when PMNs were used than when HL-60 cells were used. Nevertheless, differentiated HL-60 cells could be a convenient and standardized source of cells to evaluate the functionality of specific antibodies to vaccine candidates as a coating on fluorescent beads.

* Corresponding author. Mailing address: Research Department, Aventis Pasteur, Campus Merieux, 1541 Av. Marcel Merieux, 69280 Marcy L'Etoile, France. Phone: 33 (0)4 37 37 38 75. Fax: 33 (0)4 37 37 36 39. E-mail: Bruno.Guy{at}aventis.com.

Clinical and Diagnostic Laboratory Immunology, March 2000, p. 314-317, Vol. 7, No. 2
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2000 by the American Society for Microbiology. All rights reserved.